News

Biomune Receives USDA License for Mycoplasma Bovis Bacterin

Lenexa, KS—Biomune Company, manufacturer of Mycomune^® Mycoplasma Bovis bacterin, has announced that the company has received full USDA license approval for the bacterin. Mycomune is indicated for the prevention of mastitis in dairy cows caused by Mycoplasma bovis and was previously commercially available to veterinarians under a conditional license approval. Mycomune aids in the prevention of mastitis caused by Mycoplasma bovis and reduces duration and severity of M. bovis mastitis.

Mycoplasma mastitis has experienced a dramatic rise in incidence and is one of the most serious and costly disease problems facing dairymen today. Economic loss to the producer due to M. bovis infection in a herd can be extensive due to the lack of effective treatment for the disease, reduced milk production and the practice of culling infected cows. For further information on Mycomune call 1-800-846-0230 or visit the company web site at www.BiomuneCompany.com.

Biomune is a leading U.S. manufacturer of vaccines and bacterins for the animal health industry. Since its inception in 1988, the company’s rapid growth has been marked by technology breakthroughs and new product introductions. For further information on the full line of Biomune vaccines and bacterins call 1-800-846-0230 or log on to the company’s web site at www.BiomuneCompany.com

# # #

5-28-04